Terra Alpha Investments LLC Acquires Shares of 13,367 Danaher Co. (NYSE:DHR)

Terra Alpha Investments LLC bought a new position in Danaher Co. (NYSE:DHR) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 13,367 shares of the conglomerate’s stock, valued at approximately $3,068,000. Danaher makes up 3.1% of Terra Alpha Investments LLC’s portfolio, making the stock its 15th biggest holding.

A number of other large investors have also bought and sold shares of DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher in the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC raised its stake in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on DHR. Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 price target (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Barclays dropped their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Wells Fargo & Company decreased their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Robert W. Baird dropped their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research note on Wednesday, January 15th. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $277.76.

Danaher Stock Up 3.4 %

Shares of Danaher stock opened at $211.09 on Monday. The firm has a market cap of $150.87 billion, a PE ratio of 39.98, a P/E/G ratio of 2.66 and a beta of 0.82. The business’s 50 day simple moving average is $220.07 and its 200 day simple moving average is $240.45. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the firm earned $2.09 EPS. On average, analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is presently 24.24%.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.